Outlook on next-generation probiotics from the human gut.

Francesca De Filippis, Alessia Esposito, Danilo Ercolini

Journal: Cellular and molecular life sciences : CMLS 2022;79(2):76

PMID: 35043293

Abstract

Probiotics currently available on the market generally belong to a narrow range of microbial species. However, recent studies about the importance of the gut microbial commensals on human health highlighted that the gut microbiome is an unexplored reservoir of potentially beneficial microbes. For this reason, academic and industrial research is focused on identifying and testing novel microbial strains of gut origin for the development of next-generation probiotics. Although several of these are promising for the prevention and treatment of many chronic diseases, studies on human subjects are still scarce and approval from regulatory agencies is, therefore, rare. In addition, some issues need to be overcome before implementing their wide application on the market, such as the best methods for cultivation and storage of these oxygen-sensitive taxa. This review summarizes the most recent evidence related to NGPs and provides an outlook to the main issues that still limit their wide employment.

© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Address: Department of Agricultural Sciences, University of Naples Federico II, Naples, Italy.; Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy.; Department of Agricultural Sciences, University of Naples Federico II, Naples, Italy. [email protected].; Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy. [email protected].

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.